找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Mid-size Drugs Based on Peptides and Peptidomimetics; A New Drug Category Hirokazu Tamamura,Takuya Kobayakawa,Nami Ohashi Book 2018 The Aut

[復制鏈接]
查看: 27673|回復: 35
樓主
發(fā)表于 2025-3-21 19:54:31 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics
副標題A New Drug Category
編輯Hirokazu Tamamura,Takuya Kobayakawa,Nami Ohashi
視頻videohttp://file.papertrans.cn/634/633623/633623.mp4
概述Explains cutting-edge technical terms and new vocabulary clearly.Provides sequentially ordered descriptions ranging from basic concepts to various applications.Includes easy-to-understand figures that
叢書名稱SpringerBriefs in Pharmaceutical Science & Drug Development
圖書封面Titlebook: Mid-size Drugs Based on Peptides and Peptidomimetics; A New Drug Category Hirokazu Tamamura,Takuya Kobayakawa,Nami Ohashi Book 2018 The Aut
描述This brief describes studies conducted by the authors on mid-size drugs utilizing peptides and peptidomimetics, and on the development of anti-HIV agents. Peptides are important biological molecules and have various physiological actions. Peptide-based drug discovery may help bring about the development of useful medicines that are highly safe and show potent pharmacological effects in small doses. Recently, it has been shown that there is an important drug-like space in the mid-sized region between low- and high-molecular-weight compounds. Thus, mid-size drugs such as peptide compounds are being focused on. To date, several peptidomimetics that mimic primary, secondary, and tertiary structures of peptides have been developed to maintain and improve biological activities and actions of peptides. In this book, the features and advantages of mid-size drugs are described in detail. In addition, the merits of utilizing peptidomimetics in the development of mid-size drugs are referred to. Understanding such peptide-derived mid-size drugs will lead to a comprehensive expansion of medicinal chemistry.
出版日期Book 2018
關鍵詞Mid-size drug; Cyclic peptide; Peptidomimetic; Administration route; Anti-HIV agent
版次1
doihttps://doi.org/10.1007/978-981-10-7691-6
isbn_softcover978-981-10-7690-9
isbn_ebook978-981-10-7691-6Series ISSN 1864-8118 Series E-ISSN 1864-8126
issn_series 1864-8118
copyrightThe Author(s) 2018
The information of publication is updating

書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics影響因子(影響力)




書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics影響因子(影響力)學科排名




書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics網(wǎng)絡公開度




書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics網(wǎng)絡公開度學科排名




書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics被引頻次




書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics被引頻次學科排名




書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics年度引用




書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics年度引用學科排名




書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics讀者反饋




書目名稱Mid-size Drugs Based on Peptides and Peptidomimetics讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 21:45:07 | 只看該作者
板凳
發(fā)表于 2025-3-22 04:07:39 | 只看該作者
Book 2018ion, the merits of utilizing peptidomimetics in the development of mid-size drugs are referred to. Understanding such peptide-derived mid-size drugs will lead to a comprehensive expansion of medicinal chemistry.
地板
發(fā)表于 2025-3-22 05:15:13 | 只看該作者
1864-8118 arious applications.Includes easy-to-understand figures thatThis brief describes studies conducted by the authors on mid-size drugs utilizing peptides and peptidomimetics, and on the development of anti-HIV agents. Peptides are important biological molecules and have various physiological actions. P
5#
發(fā)表于 2025-3-22 09:13:19 | 只看該作者
6#
發(fā)表于 2025-3-22 14:51:21 | 只看該作者
7#
發(fā)表于 2025-3-22 20:57:04 | 只看該作者
Hirokazu Tamamura,Takuya Kobayakawa,Nami OhashiExplains cutting-edge technical terms and new vocabulary clearly.Provides sequentially ordered descriptions ranging from basic concepts to various applications.Includes easy-to-understand figures that
8#
發(fā)表于 2025-3-23 00:11:38 | 只看該作者
SpringerBriefs in Pharmaceutical Science & Drug Developmenthttp://image.papertrans.cn/m/image/633623.jpg
9#
發(fā)表于 2025-3-23 03:35:13 | 只看該作者
https://doi.org/10.1007/978-981-10-7691-6Mid-size drug; Cyclic peptide; Peptidomimetic; Administration route; Anti-HIV agent
10#
發(fā)表于 2025-3-23 09:33:37 | 只看該作者
SQ2P, Sequential Quadratic Constrained Quadratic Programming denen des kristallinen Siliziums abweichen, berücksichtigt werden. Nahezu alle diese abweichenden Eigenschaften lassen sich von einem grundlegenden Unterschied zwischen Si und GaAs ableiten: GaAs ist ein ., Si dagegen . (s. Abb. 3.2). Daraufhin verl?uft der Absorptionskoeffizient α(λ) des GaAs über
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 16:39
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
通江县| 洛浦县| 页游| 色达县| 靖远县| 大邑县| 金坛市| 贞丰县| 稷山县| 金门县| 天柱县| 自治县| 汽车| 繁峙县| 廊坊市| 招远市| 鄂州市| 宁强县| 博野县| 枣强县| 盐亭县| 安化县| 开化县| 河间市| 和平县| 阳山县| 鹿泉市| 和静县| 虞城县| 三明市| 平塘县| 赤峰市| 鄢陵县| 扎赉特旗| 科技| 临高县| 福安市| 禹州市| 襄樊市| 蓝山县| 韶山市|